A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2001
10/24/2001	EP0723435B1 Once-a-day metoprolol oral dosage form
10/24/2001	EP0710117B1 Phosphazene polyelectrolytes as immunoadjuvants
10/24/2001	EP0662833B1 Aqueous composition
10/24/2001	EP0641206B1 Use of cotinine to alleviate tobacco withdrawal syndrome
10/24/2001	CN1319127A Water-soluble concentrate obtained for emulgator or water-solubilising phase and complex of liquid lipophile substances of plant origin
10/24/2001	CN1319044A Method for producing layered product
10/24/2001	CN1319018A Oral drug delivery system for enhancing the bioavailability of activated glycyrrhetin
10/24/2001	CN1319016A Process for preparation of oral pharmaceutical compositions comprising biphosphonates
10/24/2001	CN1319015A Compositions containing diphosphonic acids
10/24/2001	CN1319011A Tumor tissue accumulation enhancers for drugs
10/24/2001	CN1319010A Treatment regimen for administration of phenylacetylgluta-mine, phenylacetylisoglutamize, and/or phenylacetate
10/24/2001	CN1319009A Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
10/24/2001	CN1319005A Pharmaceutical composition comprising entacapone or nitecapone as well as cross-linked cellulose derivative
10/24/2001	CN1319004A New pharmaceutical formulation
10/24/2001	CN1319003A Protein formulations
10/24/2001	CN1318416A Method of preparing oil-phase oral insulin preparation
10/24/2001	CN1318408A External-use medicine for treating sore ulcer, wound, rheumatism and other diseases and its preparation
10/24/2001	CN1318399A Radix Isatidis injecta and its preparation
10/24/2001	CN1318388A Eye disease preventing oral liquid and its preparation
10/24/2001	CN1318380A Compound spot-eliminating ointment and its preparation
10/24/2001	CN1318369A Preparation of oral coated medicine grains
10/24/2001	CN1318368A Application of nanometer technology in Chinese medicine form improvement
10/24/2001	CN1318317A Weight-reducing and blood lipoid reducing health food
10/24/2001	CN1318316A Immunity-regulating and fatigue-resisting health food
10/24/2001	CN1073626C Productive technology for A-type botulism crystalline toxin and frozen-dried protective liquid needed for producing said toxin
10/24/2001	CN1073473C Electrostatic coating process and apparatus of small falling objects
10/24/2001	CN1073446C Superfine cordyceps sinensis powder and its prep.
10/24/2001	CN1073435C Infantile cough plaster and its production method
10/24/2001	CN1073421C Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitor and beta adrenergic antagonist
10/24/2001	CN1073420C Vermifuge composition for farm animal
10/24/2001	CN1073414C Anaesthetic
10/24/2001	CN1073413C Transdermal therapeutic system and its prep.
10/24/2001	CN1073412C Method for prepn. of macromolecule microcapsule
10/24/2001	CN1073361C 苁蓉茶 BREE tea
10/23/2001	US6307056 Inhibit or modulate protein kinases, in particular jnk protein kinases.
10/23/2001	US6306922 Macromer polymers crosslinked by photopolymerization
10/23/2001	US6306915 Oligosaccharides of uronic acid, glucosamine, galactose, and mannose, or one uronic acid; r.sub.2 is an alkyl group, emulsifier of the present invention has marked moisturizing effect, skin roughening preventing effect
10/23/2001	US6306914 Progestin therapy for maintaining amenorrhea
10/23/2001	US6306902 Oxaliplatin formulations
10/23/2001	US6306900 Enteric coated pharmaceutical compositions
10/23/2001	US6306898 Mixture of vitamin e and squalane for skin disorders
10/23/2001	US6306896 Pharmaceutically active composition containing artemisinine and/or derivative of artemisinine
10/23/2001	US6306894 Seals on containers for piclitaxel and sealed containers and drugs
10/23/2001	US6306879 Isotonic glucose solution
10/23/2001	US6306856 Dissolving pyridonecarboxylic acid or salt, mixing with glycyrrhizic acid with acid
10/23/2001	US6306843 Solvents, solutions and mixtures of dimethylisosorbide, propylene glycol or diethylene glycol monoethyl ether, cyclic acid imide and/or sulfaminic acid of a compound of aromatic alcohol or ether
10/23/2001	US6306841 Treatment of female sexual dysfunction
10/23/2001	US6306838 Targeted vesicular constructs for cyto protection and treatment of h. pylori
10/23/2001	US6306825 Cyclosporin galenic forms
10/23/2001	US6306789 Mucoadhesive granules of carbomer suitable for oral administration of drugs
10/23/2001	US6306655 Antisense inhibition of C/EBP alpha expression
10/23/2001	US6306612 Methods of facilitating vascular growth
10/23/2001	US6306598 Nucleic acid-coupled colorimetric analyte detectors
10/23/2001	US6306444 Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same
10/23/2001	US6306440 Forming solution of insulin in solvent and a substance that enhances absorption of insulin in lower respiratory tract; removing solvent to obtain solid; forming into powder; incorporating powder into dry powder inhaler device
10/23/2001	US6306439 Expandable pharmaceutical forms
10/23/2001	US6306438 For therapy of pain; storgae stability
10/23/2001	US6306437 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
10/23/2001	US6306436 Stabilized, acid-free formulation for sustained release of bupropion hydrochloride
10/23/2001	US6306435 Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
10/23/2001	US6306434 Pharmaceutical composition comprising cyclosporin solid-state microemulsion
10/23/2001	US6306433 Method of preparing pharmaceutical compositions
10/23/2001	US6306432 High and low load formulations of IGF-I in multivesicular liposomes
10/23/2001	US6306431 Dermal drug delivery system
10/23/2001	US6306429 Throat drops suitable for relief of cough and cold symptoms
10/23/2001	US6306428 Controlled active substance release is accomplished with rolled or folded layers of a polymer film, that contain a pharmaceutically active substance
10/23/2001	US6306427 Useful for nutritional and/or medicinal supplementation of ruminants
10/23/2001	US6306426 Implant device with a retinoid for improved biocompatibility
10/23/2001	US6306425 Time release agents; therapy of drug abuse and drug dependence
10/23/2001	US6306423 Biocompatible implant for continuous in vivo release of a neurotoxin over a treatment period extending from one month to five years
10/23/2001	US6306422 Compositions and devices for controlled release of active ingredients
10/23/2001	US6306421 Therapeutic inhibitor of vascular smooth muscle cells
10/23/2001	US6306420 Obtaining implantable device for automatic delivery of an active ingredient according to adjustable delivery profile; providing energy to controller and actuator to move drug from reservoir to transit area to deliver to body fluids
10/23/2001	US6306419 For wound dressing for covering wound; coated implantable medical devices,
10/23/2001	US6306408 Composition containing humidity regulators, for tissue products
10/23/2001	US6306407 Cosmetics
10/23/2001	US6306406 Drug delivery system involving interaction between protein or polypeptide and hydrophobic biodegradable polymer
10/23/2001	US6306405 Use of microparticles combined with submicron oil-in-water emulsions
10/23/2001	US6306392 Prevention and/or treatment of alterations of those organs which perform metabolic function, such as liver, kidneys, cardiovascular system and brain; for therapy of hepatosis, nephropathies and cardiovascular or cerebral damage damage
10/23/2001	US6306391 Coating agent and/or microorganism to provide a protective barrier; combining agent and microorganism into form of capsules or tablets; barrier protects microogranism from effect of anti-infective agent
10/23/2001	US6306385 Method of protecting against chronic infections
10/23/2001	US6306369 Comprising bronchodilatory agent, anti-infalmmatory agent and 1,1,1,2-tetrafluoroethane propellent; for administration of medicaments by inhalation; for therapy of respiratory system disorders
10/23/2001	US6306368 Use in administration of medicaments by inhalation
10/23/2001	US6306345 Drying biological solution or suspension in a chamber by boiling under vacuum to form mechanically stable foam; crushing foam to form powder
10/23/2001	US6306333 Process for making cellulose ethers having reduced yellowing and discoloration
10/23/2001	US6306125 Angiogenic implant delivery system and method
10/23/2001	CA2302963C Soft gelatin capsule manufacture
10/23/2001	CA2236368C Sublingual and buccal administration of selegiline
10/23/2001	CA2223817C Compositions for the treatment of rheumatoid-based arthritic diseases
10/23/2001	CA2217227C Use of a partial or complete extract of not fermented camellia sinensis l. for the preparation of a medicament, a medical care product, a cosmetic preparation or a food complementary product
10/23/2001	CA2211284C Multiple unit sustained release dosage form
10/23/2001	CA2203566C Percutaneously administration preparation
10/23/2001	CA2203310C Compressed matrix for slow release of salt of tianeptine sodium following oral administration
10/23/2001	CA2183862C Stabilized composition for oral administration of peptides
10/23/2001	CA2173709C Cristallyed bead made from a supercooled product, and process for obtaining same
10/23/2001	CA2134376C Combinations of polymers for use in physiological tear compositions
10/23/2001	CA2046310C Preparation of pharmaceutical and other matrix systems by solid-state dissolution
10/23/2001	CA2043625C Skin preparations for external use
10/23/2001	CA2039655C Sheet for containing micronized powdered medicament
10/18/2001	WO2001077988A2 System and method for rapidly customizing a design and remotely manufacturing biomedical devices using a computer system

1 ... 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 ... 2991